Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BridgeBio Oncology Therapeutics, Inc. | 1,103,837 | reported | 10 May 2026 | tx 5+1,717,684−1,047 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 May 2026 | GRANT_AWARD | BridgeBio Oncology Therapeutics, Inc. | 1,103,837 | 0.00 USD | deriv |
| 01 Apr 2026 | TAX_WITHHOLDING | BridgeBio Oncology Therapeutics, Inc. | 1,047 | 9.03 USD | |
| 10 Mar 2026 | GRANT_AWARD | BridgeBio Oncology Therapeutics, Inc. | 46,670 | 0.00 USD | |
| 10 Mar 2026 | GRANT_AWARD | BridgeBio Oncology Therapeutics, Inc. | 210,000 | 0.00 USD | deriv |
| 26 Aug 2025 | GRANT_AWARD | BridgeBio Oncology Therapeutics, Inc. | 357,177 | 0.00 USD | deriv |